How many UTIs constitute a recurrent UTI?

A recurrent UTI is medically defined as two or more confirmed urinary tract infections within a 6-month period, or three or more infections within a 12-month period.

Why do I keep getting UTIs even after taking antibiotics?

Recurrent UTIs despite antibiotic treatment can occur due to antibiotic resistance, reinfection, incomplete eradication, or underlying anatomical or hormonal factors. A specialist evaluation with urine culture is essential.

Can recurrent UTIs be prevented?

Yes - recurrent UTIs can often be significantly reduced or eliminated with the right prevention strategy including low-dose antibiotic prophylaxis, vaginal estrogen therapy for postmenopausal women, behavioral modifications, and evidence-based supplements.

Do I need to see an infectious disease specialist or can my primary care doctor treat recurrent UTIs?

While primary care physicians can treat individual UTI episodes, recurrent UTIs benefit significantly from infectious disease specialist evaluation with specialized training in antibiotic resistance patterns and evidence-based prevention strategies.

Is long-term antibiotic use for UTI prevention safe?

Low-dose antibiotic prophylaxis for recurrent UTI prevention has a well-established safety record when properly managed. Specialists carefully select the safest antibiotic at the lowest effective dose and regularly reassess.

Does Atlas IDP accept insurance for recurrent UTI treatment?

Yes, Atlas Infectious Disease Practice accepts most major insurance plans. Call (561) 995-6971 to verify your specific insurance coverage before your appointment.

Federal Government Changes May Influence Avian Influenza Surveillance and Disease Prevention

endTB Trial Paves Way for Shorter, Cheaper, and Safer Rifampin-Resistant TB Treatments

Five All-Oral Regimens Show Efficacy in the Phase 3 endTB Trial for Rifampin-Resistant TB

Top 5 Infectious Disease News Stories Week of February 1-8

FDA Advises Restaurants and Retailers Not to Serve or Sell Certain Oysters

FDA Approves Aztreonam and Avibactam for Complicated Intra-Abdominal Infections

Study Links Genetic Variations in Cryptococcus neoformans to Disease Outcomes

American Public Health Association’s Opposition to RFK Jr’s HHS Nomination

New Virus Discovery Highlights Zoonotic Risks in North America

Health Equity is Essential to Overcoming Antimicrobial Resistance

Schedule an Appointment

Quick Links

Patient Forms

Contact Us